Table 1.
Characteristics of the basilar occlusion patients
| Patient | Age (sex) | Baseline NIHSS | rtPA dosage (mg) | ESP | PTR (hours) | STP (hours) | NIHSS at discharge | mRS at 3 months |
|---|---|---|---|---|---|---|---|---|
| 1 | 67 (M) | 20 | None | No | 2.2 | 2 | 12 | 4 |
| 2 | 70 (F) | 30 | None | No | 4.5 | 3.4 | Dead | 6 |
| 3 | 68 (M) | 35 | 20 | Yes | 3.8 | 2.7 | Dead | 6 |
| 4 | 76 (M) | 22 | 20 | No | 1.2 | 3.2 | 10 | 3 |
| 5 | 54 (F) | 28 | 20 | No | 4.3 | 4.3 | Dead | 6 |
| 6 | 56 (M) | 26 | 20 | No | 2.4 | 4.1 | 4 | 1 |
| 7 | 56 (F) | 30 | 10 | No | 1.8 | 2.4 | 16 | 5 |
| 8 | 46 (M) | 22 | None | Yes | 2 | 3 | 0 | 0 |
| 9 | 57 (F) | 30 | 13 | No | 2.7 | 4.2 | 8 | 3 |
| 10 | 58 (M) | 24 | 20 | No | 3.4 | 2 | 3 | 2 |
| 11 | 31 (M) | 32 | 30 | Yes | 4.5 | 2.8 | Dead | 6 |
| 12 | 56 (M) | 25 | None | No | 1.5 | 2.2 | 2 | 1 |
| 13 | 55 (F) | 18 | None | No | 2 | 2.6 | 4 | 2 |
| 14 | 65 (M) | 22 | None | No | 1.6 | 3.5 | 6 | 4 |
| 15 | 71 (F) | 20 | None | No | 3.2 | 5.0 | Dead | 6 |
| 16 | 60 (M) | 25 | None | No | 3.0 | 4.2 | 7 | 3 |
| 17 | 67 (M) | 30 | None | No | 2.8 | 3.2 | 5 | 2 |
| 18 | 59 (M) | 28 | None | No | 2.4 | 3.6 | 8 | 3 |
ESP = emergent stent placement, F = female, M = male, mRS = modified Rankin scale, NIHSS = National Institutes of Heath Stroke Scale, PTR = time from femoral puncture to recanalization, rtPA = recombinant tissue plasminogen activator, STP = time from onset of symptoms to groin puncture.